Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Elizabeth Gleeson is a leading surgical oncologist whose research is transforming the landscape of hepatopancreatobiliary (HPB) surgery, with a particular focus on the comparative effectiveness of minimally invasive techniques. Her major contributions center on rigorously evaluating the adoption and outcomes of laparoscopic versus robotic approaches for complex procedures like hepatectomy and pancreatectomy. Her landmark 2020 study, "Minimally Invasive Hepatectomy in North America: Laparoscopic Versus Robotic" (41 citations), provided critical early evidence on the safety and efficacy of these competing technologies. More recently, Dr. Gleeson has spearheaded groundbreaking transatlantic analyses, using large international registries to uncover significant variations in patient selection and outcomes for minimally invasive distal pancreatectomy and pancreatoduodenectomy between North America and Europe. This work, published in 2024, is vital for establishing global benchmarks and optimizing surgical care. By highlighting these international differences, her research is directly shaping best practices and informing the design of future clinical trials, making her a pivotal voice in the evolution of modern HPB surgery.